← All Sponsors
SPONSOR

Definium Therapeutics US, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Generalized Anxiety Disorder
NCT06741228 Phase 3
Recruiting

A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)

Generalized Anxiety Disorder
United States View Trial →